Akari Therapeutics (AKTX) Receivables (2011 - 2013)

Akari Therapeutics (AKTX) reported Receivables of $6000.0 for Q4 2013, down 50.0% on a YoY basis from $12000.0 in Q4 2012, and down 50.0% sequentially from $12000.0 in Q4 2012.

Akari Therapeutics (AKTX) Receivables (2011 - 2013) Analysis & Trends

Akari Therapeutics (AKTX) has 3 years of Receivables data on file, last reported at $6000.0 in Q4 2013.

  • For the quarter ending Q4 2013, Receivables fell 50.0% year-over-year to $6000.0; the trailing twelve-month figure through Dec 2013 stood at $6000.0 (down 50.0% YoY), and the FY2013 full-year result was $6000.0, down 50.0% from the prior year.
  • Receivables eased to $6000.0 in Q4 2013, from $12000.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $19000.0 in Q4 2011 to a low of $6000.0 in Q4 2013.
  • A 3-year average of $12333.3 and a median of $12000.0 in 2012 frame the typical range for Receivables.
  • Across the five-year window, Receivables tumbled 36.84% in 2012 and slumped 50.0% in 2013, its largest moves.
  • Tracing AKTX's Receivables over 3 years: stood at $19000.0 in 2011, then slumped by 36.84% to $12000.0 in 2012, then tumbled by 50.0% to $6000.0 in 2013.
  • Business Quant data shows AKTX's Receivables at $6000.0 in Q4 2013, $12000.0 in Q4 2012, and $19000.0 in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 4.97 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 938.02 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 883.96 Mn

Historic Data

Download Data
DateValue
Dec 31, 2013 6,000.00
Dec 31, 2012 12,000.00
Dec 31, 2011 19,000.00